While those figures may please company shareholders, that kind of consolidation and profit puts too much control over food supplies into too few places, according to critics like Scanlan.

'We're used to flu vaccines being reformulated every year because new strains come along,' said Dr Chris Scanlan of the Department of Biochemistry at the University of Oxford, who led the research.